Ocuphire Pharma Inc (OCUP)

$1.17 -0.16 (-12.03%)
Market Cap 30.33M
Revenue (ttm) 19.05M
Net Income (ttm) -9.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -52.44%
Debt to Equity Ratio 0.00
Volume 676,700
Avg Vol 130,434
Day's Range N/A - N/A
Shares Out 25.92M
Stochastic %K 34%
Beta 0.20
Analysts Strong Sell
Price Target $19.00
TreyK1409
TreyK1409 Mar. 21 at 8:57 AM
$IRD $OCUP I would strongly advise any long-term shareholders who have been confused by some the events over the last couple of years to read the ”Background to the Solicitation” section of the preliminary proxy statement. It answered a lot of questions for me.
1 · Reply
JB_Research
JB_Research Mar. 18 at 7:24 PM
$OCUP "Opus and Viatris Unit Sue Sandoz to Block Copy of Ryzumvi Eye Drug..." $IRD https://news.bloomberglaw.com/ip-law/opus-viatris-unit-sue-sandoz-to-block-copy-of-ryzumvi-eye-drug
0 · Reply
GoodInvestor
GoodInvestor Mar. 6 at 9:14 PM
$OCUP Stanks
0 · Reply
TickrTalk0007
TickrTalk0007 Feb. 9 at 4:05 AM
$OCUP $ZNTL cam Gallagher drove 2 companies into ground. SEC should ban him from taking companies public or being on Board. So many things wrong with Opus merger. two of current c suite guys owned opus stock when it was private. huge conflict of interest if they didn’t recuse themselves.
0 · Reply
Novice1a
Novice1a Jan. 29 at 4:29 PM
$OCUP https://x.com/i/grok/share/bOHSQ6OxTgxQX5xBrCX27k4sz
0 · Reply
Maynard_Keysian
Maynard_Keysian Jan. 9 at 5:11 PM
$OCUP Please don't infect the new board/ticker with this nonsense.
0 · Reply
Novice1a
Novice1a Jan. 9 at 12:57 PM
$IRD $OCUP
0 · Reply
Novice1a
Novice1a Jan. 9 at 12:55 PM
$OCUP $IRS this appears to be personal. If you're going to make statements publicly that are negative to stock holders you should share the receipts.
0 · Reply
Novice1a
Novice1a Jan. 9 at 3:52 AM
$OCUP $IRD Erik?
0 · Reply
Novice1a
Novice1a Jan. 9 at 3:48 AM
$OCUP $IRD accountable for what?
0 · Reply
Latest News on OCUP
No data available.
TreyK1409
TreyK1409 Mar. 21 at 8:57 AM
$IRD $OCUP I would strongly advise any long-term shareholders who have been confused by some the events over the last couple of years to read the ”Background to the Solicitation” section of the preliminary proxy statement. It answered a lot of questions for me.
1 · Reply
JB_Research
JB_Research Mar. 18 at 7:24 PM
$OCUP "Opus and Viatris Unit Sue Sandoz to Block Copy of Ryzumvi Eye Drug..." $IRD https://news.bloomberglaw.com/ip-law/opus-viatris-unit-sue-sandoz-to-block-copy-of-ryzumvi-eye-drug
0 · Reply
GoodInvestor
GoodInvestor Mar. 6 at 9:14 PM
$OCUP Stanks
0 · Reply
TickrTalk0007
TickrTalk0007 Feb. 9 at 4:05 AM
$OCUP $ZNTL cam Gallagher drove 2 companies into ground. SEC should ban him from taking companies public or being on Board. So many things wrong with Opus merger. two of current c suite guys owned opus stock when it was private. huge conflict of interest if they didn’t recuse themselves.
0 · Reply
Novice1a
Novice1a Jan. 29 at 4:29 PM
$OCUP https://x.com/i/grok/share/bOHSQ6OxTgxQX5xBrCX27k4sz
0 · Reply
Maynard_Keysian
Maynard_Keysian Jan. 9 at 5:11 PM
$OCUP Please don't infect the new board/ticker with this nonsense.
0 · Reply
Novice1a
Novice1a Jan. 9 at 12:57 PM
$IRD $OCUP
0 · Reply
Novice1a
Novice1a Jan. 9 at 12:55 PM
$OCUP $IRS this appears to be personal. If you're going to make statements publicly that are negative to stock holders you should share the receipts.
0 · Reply
Novice1a
Novice1a Jan. 9 at 3:52 AM
$OCUP $IRD Erik?
0 · Reply
Novice1a
Novice1a Jan. 9 at 3:48 AM
$OCUP $IRD accountable for what?
0 · Reply
Novice1a
Novice1a Jan. 9 at 3:41 AM
$OCUP $IRD are you a whistle blower? You signed up today to tell us that?
0 · Reply
Richardrodgers1
Richardrodgers1 Jan. 9 at 1:05 AM
$OCUP Richard Rodgers and Cam Gallagher = garbage. cant wait to watch the stock go to zero given the company has a value of about .01. hope they have good insurance since the stockholders declined to allow the the board to not be personally held accountable…
2 · Reply
Novice1a
Novice1a Jan. 8 at 4:57 PM
$IRD $OCUP
0 · Reply
Novice1a
Novice1a Jan. 8 at 4:16 PM
$IRD $RHHBY $OCUP https://www.reuters.com/markets/deals/roche-complete-acquisition-us-biopharma-company-poseida-2025-01-08/. Roche you can buy $IRD at the right price.
0 · Reply
Novice1a
Novice1a Jan. 7 at 10:17 PM
$IRD $OCUP https://ir.stockpr.com/opusgtx/sec-filings-email/content/0001140361-25-000467/ef20041180_8ka.htm
0 · Reply
Arbtrag
Arbtrag Jan. 7 at 7:35 PM
$OCUP reason we stopped at 154sh is because that is where blackrock bought in
1 · Reply
Novice1a
Novice1a Jan. 7 at 5:47 PM
$OCUP $IRD you forgot to mention the crown jewel of $IRD the APX3330 SPA approval that just happened recently.
0 · Reply
Novice1a
Novice1a Jan. 7 at 5:36 PM
$IRD $OCUP baseline
0 · Reply
Novice1a
Novice1a Jan. 7 at 4:14 PM
$IRD $OCUP institutional buying starting?
1 · Reply
Novice1a
Novice1a Jan. 6 at 11:23 PM
$IRD $OCUP https://ir.stockpr.com/opusgtx/sec-filings-email/content/0000905148-25-000039/form4.html
1 · Reply
Novice1a
Novice1a Jan. 6 at 11:16 PM
$IRD $OCUP https://ir.stockpr.com/opusgtx/sec-filings-email/content/0000905148-25-000038/form4.html.
0 · Reply
signaljumper
signaljumper Jan. 6 at 4:20 PM
$IRD $OCUP my favorit Biotechplay 25M float Cash/Sh 1.08 Upcoming catalyst LYNX-2 Ph 3 TLD Q1 2025 VEGA-3 Ph 3 TLD 1H 2025 wulfwave target is around 4$ if Q1 Data is good than target 6.50$+ why? last ride before data was in Aug 22 from 1.95 to 6.50$
1 · Reply